在低氧微环境中准癌症干细胞并防止瘤发生的小分子策略
Ji Hyeon Kim1, Peter Verwilst1, Miae Won1
1Department of Chemistry, Korea University, Seoul 02841, Korea.
Journal of the American Chemical Society
|August 10, 2021
概括
一种新型的小分子AzCDF在低氧环境中向乳腺癌干细胞 (BCSCs). 这种方法有效地减少了瘤的生长和转移,
科学领域:
- 癌症学
- 分子生物学
- 药物发现
背景情况:
- 乳腺癌是一种由癌症干细胞 (CSC) 驱动的异质性疾病.
- 乳腺癌干细胞 (BCSC) 有关转移和复发.
- BCSCs在低毒性中壮成长, 赋予化学疗法的抵抗力.
研究的目的:
- 开发一种新的小分子结构, AzCDF,用于针对性治疗BCSC.
- 评估AzCDF在低氧瘤环境中的有效性.
- 调查AzCDF在预防瘤形成方面的潜力.
主要方法:
- 含有低氧触发剂阿西胺 (Az) 和黄素 (CDF) 的 AzCDF 的设计.
- 在体外和体内研究以评估AzCDF对BCSC的影响.
- 评估AzCDF对CSC迁移,瘤生长和瘤发生的影响.
主要成果:
- 在低毒性条件下,AzCDF选择性地向BCSCs.
- AzCDF降低了中枢细胞的迁移,并延缓了瘤的生长.
- 在体内,AzCDF有能力降低瘤发生率.
结论:
- AzCDF代表了选择性BCSC向的低氧性分子平台.
- 这项研究展示了首个在动物模型中预防瘤形成的向性小分子.
- AzCDF为耐火性乳腺癌提供了一个有前途的治疗策略.
相关概念视频
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Therapies
8.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K


